HUTCHMED announces savolitinib approved in China for patients with lung cancer with MET exon 14 skipping alterations

by NASDAQ Market News June 22, 2021

NASDAQ Market News
Click here to email author

Sorrento Enters Into Multi-Year Cooperative Research and Development Agreement With the U.S. Naval Medical Research Unit – No. 3 (NAMRU-3) For Pandemic Preparedness Combating COVID-19

Celon Pharma Files for Approval of Phase II Trial of CPL’280, a Second Generation GPR40 Agonist, in Type 2 Diabetes

Ads